Financhill
Back

GeneDx Holdings Quote, Financials, Valuation and Earnings

Buy
58

WGS
GeneDx Holdings

Last Price:
22.36
Seasonality Move:
-0.59%

7 Day Trial

ALL ACCESS PASS

$ 7

GeneDx Holdings Price Quote

$22.36
-0.03 (-6.91%)
(Updated: May 18, 2024 at 5:56 AM ET)

GeneDx Holdings Key Stats

Buy
58
GeneDx Holdings (WGS) is a Buy

Day range:
$22.27 - $24.40
52-week range:
$1.16 - $21.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.41
P/B ratio:
2.62%

Volume:
345.7K
Avg. volume:
690.4K
1-year change:
262%
Market cap:
$542.6M
Revenue:
$202.6M
EPS:
$-5.18

How Much Does GeneDx Holdings Make?

Is GeneDx Holdings Growing As A Company?

  • What Is GeneDx Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.45%
  • What Is GeneDx Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

GeneDx Holdings Stock Price Performance

  • Did GeneDx Holdings Stock Go Up Last Month?
    GeneDx Holdings share price went up by 143.37% last month
  • Did WGS's Share Price Rise Over The Last Year?
    WGS share price rose by 262% over the past 1 year

What Is GeneDx Holdings 52-Week High & Low?

GeneDx Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy GeneDx Holdings?

  • How Much Debt Does GeneDx Holdings Have?
    Total long term debt quarterly is $52.3M
  • How Much Cash Does GeneDx Holdings Have?
    Cash and short term investments quarterly total is $112.9M
  • What Is GeneDx Holdings’s Book Value Per Share?
    Book value per share is 7.93

Is GeneDx Holdings Cash Flow Positive?

  • What Is WGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$141M
  • What Is GeneDx Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $53.1M
  • What Is GeneDx Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$42.4M

GeneDx Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    WGS return on invested capital is -46.94%
  • What Is GeneDx Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -29.97%
  • What Is WGS Return On Equity?
    ROE is a measure of profitability and is -51.37%

GeneDx Holdings Earnings Date & Stock Price

GeneDx Holdings Competitors

  • Who Are GeneDx Holdings's Competitors?
    Below is a list of companies who compete with GeneDx Holdings or are related in some way:
    • American Well Corp (AMWL)
    • Doximity Inc (DOCS)
    • GoodRx Holdings Inc (GDRX)
    • GE HealthCare Technologies Inc (GEHC)
    • Privia Health Group Inc (PRVA)

GeneDx Holdings Dividend Yield

Data Unavailable

GeneDx Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 51.09%
Revenue: 44.7% 26.23%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 15.25
Downside from Last Price: -31.89%

Major Shareholders

  • How many WGS shares are owned by institutional investors?
    96.4M WGS shares are owned by institutional investors
  • How many WGS shares are owned by insiders?
    1.3M WGS shares are owned by insiders